INS and central nervous system disorder: Insulin directly affects inflammatory cells in the brain, reduces the release of pro-inflammatory cytokine TNFα, and may have an important role in the mechanism of action of insulin-based therapies currently being considered for CNS disorders (Brabazon et al., 2018).